International Stem Cell Corporation to Present at the Rodman and Renshaw Global Investment Conference
September 01, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - September 01, 2015) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com, ISCO or the Company), a California-based biotechnology company...
International Stem Cell Corporation Announces Record Net Income in Second Quarter 2015
August 18, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - August 18, 2015) - International Stem Cell Corporation (OTCQB: ISCOD) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company...
International Stem Cell Corporation Completes Clinical Testing of a New Compound
August 06, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - August 06, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical...
International Stem Cell Corporation Submits Remaining Requested Safety Study Report for Clinical Trial Authorization
July 30, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - July 30, 2015) - International Stem Cell Corporation (ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products,...
International Stem Cell Corporation Announces 1:150 Reverse Stock Split
July 28, 2015 13:04 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - July 28, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical...
International Stem Cell Corporation to Present at International Society for Cellular Therapy Annual Meeting
May 27, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - May 27, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical...
International Stem Cell Corporation Announces 2015 First Quarter Results
May 13, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - May 13, 2015) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company...
International Stem Cell Corporation Publishes Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation
April 21, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - April 21, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical...
International Stem Cell Corporation Presents Data From Parkinson's Disease Program at AAN Annual Meeting
April 14, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - April 14, 2015) - International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical...
International Stem Cell Corporation Demonstrates Reversal of Neurological Stroke Symptoms Using Neural Stem Cells
April 07, 2015 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - April 07, 2015) - Human parthenogenetic neural stem cells (ISC-hpNSC) can significantly reduce neurological dysfunction after a stroke in animal models, according to...